使用抗Aβ初原纤维抗体的治疗方法
本文披露了基于ARIA事件或脑出血的风险对患有阿尔茨海默病(AD)或疑似患有AD或与脑中淀粉样蛋白积累相关的另一种障碍的受试者进行选择、监测和治疗的方法。本文还披露了治疗患有或疑似患有AD的受试者的方法,这些方法包括皮下施用抗Aβ初原纤维抗体。
APPLICANTS
Browse source applicant names and unchanged name fields from imported patent records.
These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.
This page matches the complete original name field. It may contain multiple applicants or another recorded party role. Name boundaries and legal identities have not been verified; punctuation is preserved, not split.
1 indexed patent records
Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.
Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.
Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.
Search patents with this applicant condition